Q&A with Thelma Bueno, Sr. Clinical Project Manager at genae Americas
Q: What unique aspects of a valve subject population make enrollment/recruitment/retention particularly difficult?
A: For valve studies, the innovative nature of the valve clinical trial makes it someone less difficult for the subjects to decide for this route; however, the fact that porcine or bovine valves do not require lifetime use of anticoagulant treatment might have the patients reconsider participating in a clinical trial.
Some of the patients involved in clinical trials have co-morbidities that can affect their willingness or ability to continue with the required follow-up; however, I have seen that the patients see such a great change in their quality of life that they do return to their follow-ups.
Discover our other Q&A videos:
• How do you go about ensuring that a site is appropriate for a valve study?
• Are there any specific pieces of information you would include in a site feasibility survey for a valve trial?
• Are there any barriers to sites getting approved in a valve trial?
• For valve studies, please discuss some specific quirks or intricacies that prevent sites from meeting their enrollment targets?
• Are there procedures specific to the conduct of a valve trial that sponsors/principal investigators should be aware of?
• Is there anything in the design of a valve trial that you foresee as a source of difficulty when it comes to executing?
Want to hear more about our services or how we can support your clinical trial? Feel free to contact us with any questions you may have.Contact us